Trial intelligence / Profile preview

Protamine infusion speed and adverse reactions in cardiac surgery

ChiCTR2500095481Phase 4Not yet recruiting

Sponsor
Department of Anesthesiology, Guizhou Provincial People's Hospital
Start
Jan 2025
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of protamine (3 arms), sponsored by Department of Anesthesiology, Guizhou Provincial People's Hospital. Primary endpoints: mean arterial pressure, heart rate and 2 more. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

protamine

Beyond the preview

Go deeper on ChiCTR2500095481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call